Become A Featured Company

As Canada’s Cannabis Industry Scales Up, Aurora Cannabis is Poised for Powerful Growth

Ryan Allway

April 26th, 2016

News, Top Story

The cannabis industry may have been taboo under former Prime Minister Stephen Harper and his Conservative Party, but a new government has brought a very different perspective. Justin Trudeau’s Liberal Party won a strong majority government in the October 2015 federal election, with legalization of recreational marijuana as a key plank in their campaign platform. The Liberals now have a clear mandate to reform Canada’s outdated marijuana laws, and have begun to lay the groundwork for a legal recreational market. On April 20, 2016, the government announced that legislation to legalize cannabis would be introduced in the spring of 2017.

Existing, proven licensed producers under the Marihuana for Medical Purposes Regulations (MMPR), such as Aurora Cannabis (CSE: ACB) (OTC: ACBFF), Organigram Holdings (TSXV: OGI) (OTC: OGRMF), Emerald Health Therapeutics (TSXV: EMH) (OTC: TBQBF) and Mettrum Health (TSXV: MT) (OTC: MQTRF), will have significant advantages when it comes to supplying what promises to be a large and lucrative recreational market. The success to date of a burgeoning legal recreational market in Colorado has already demonstrated the tremendous potential for Canada, which has a population that’s about seven times larger, at 35 million.

 A Natural Low-Cost Producer

Aurora Cannabis was founded on the premise that legal medicinal cannabis should be of the highest quality, affordable, and easy to access. With an $11.5 million 55,200-square-foot production facility located near Calgary, the company combines natural elements like fresh mountain water with state-of-the-art technology to provide among the cleanest, safest products on the market – without using pesticides, and without employing techniques such as irradiation, which can alter certain desirable medicinal properties in the cannabis plant.

The company’s vertically integrated business model, use of natural resources, and presence in Alberta have enabled it to beat competitors elsewhere in Canada in terms of production costs. Alberta has some of the lowest tax rates and electricity costs in the country, an abundance of farm credit programs, as well as grants available to innovative companies in the agricultural sector. By leveraging these advantages, the company’s strains are offered at just $8 per gram (with $5 per gram compassionate pricing).

Earlier this year, the company received approval from Health Canada to produce derivative cannabis products, such as oils and other extracts. Of particular importance, ingestible cannabis derivatives are ideal for people who need or prefer a delivery system that does not involve smoking. These products represent new revenue streams, and are expected to increase net margin substantially by the end of 2016.

Powering-up Aurora’s Marketing Efforts

Aurora Cannabis is performing well on the important metric of patient acquisition, having surpassed 1,000 active registered patients in its first three months of product sales – believed to be the fastest any licensed producer has reached that milestone. The company recently ramped-up its marketing outreach efforts with the appointment of Mr. Cam Battley as Senior Vice President of Communications and Medical Affairs.

On April 6, 2016, Mr. Battley was elected to the Board of Directors of the Canadian Medical Cannabis Industry Association (CMCIA), the trade association for licensed producers under Health Canada’s MMPR program, and he is currently the Chair of the Advocacy Committee for the Association. Previously, he served as the Vice President of Communications and Corporate Development for Bedrocan Canada, another leading licensed producer.

In his new role, Mr. Battley will be responsible for external communications, investor relations, collaboration with the medical community, business development, and patient and other stakeholder initiatives. With a dynamic, high-profile background, Mr. Battley will help the company capitalize on its inherent advantages as high quality, low- cost producer. This could translate into helping Aurora capture greater market share and entrench its position as a recognized best-of-breed industry leader.

Looking Ahead 

Aurora Cannabis is well positioned within Canada’s fast-growing cannabis industry to continue to capitalize on its emerging role as an industry frontrunner – and benefit from Prime Minister Trudeau’s bold move to legalize recreational cannabis. Shareholders should position themselves as well to reap the potential rewards.

For more information, visit the company’s website at www.auroramj.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading